This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

A National Survey on the Regulation of Syringes and Needles

Lawrence O. Gostin, JD; Zita Lazzarini, JD, MPH; T. Stephen Jones, MD, MPH; Kathleen Flaherty, JD

JAMA. 1997;277(1):53-62.

Abstract
We report the results of a survey of laws and regulations governing the sale and possession of needles and syringes in the United States and its territories and discuss legal and public health proposals to increase the availability of sterile syringes, as a human immunodeficiency virus (HIV) transmission prevention measure, for persons who continue to inject drugs. Every state, the District of Columbia (DC), and the Virgin Islands (VI) have enacted state or local laws or regulations that restrict the sale, distribution, or possession of syringes. Drug paraphernalia laws prohibiting the sale, distribution, and/or possession of syringes known to be used to introduce illicit drugs into the body exist in 47 states, DC, and VI. Syringe prescription laws prohibiting the sale, distribution, and possession of syringes without a valid medical prescription exist in 8 states and VI. Pharmacy regulations or practice guidelines restrict access to syringes in 23 states. We discuss the following legal and public health approaches to improve the availability of sterile syringes to prevent bloodborne disease among injection drug users: (1) clarify the legitimate medical purpose of sterile syringes for the prevention of HIV and other blood-borne infections; (2) modify drug paraphernalia laws to exclude syringes; (3) repeal syringe prescription laws; (4) repeal pharmacy regulations and practice guidelines restricting the sale of sterile syringes; (5) promote professional training of pharmacists, other health professionals, and law enforcement officers about the prevention of blood-borne infections; (6) permit local discretion in establishing syringe exchange programs; and (7) design community programs for safe syringe disposal.

Author Affiliations
From the Georgetown/Johns Hopkins Program in Law and Public Health, Washington, DC, and Baltimore, Md (Mr Gostin and Ms Flaherty); Harvard School of Public Health, Boston, Mass (Ms Lazzarini); and the Centers for Disease Control and Prevention, Atlanta, Ga (Dr Jones).

Footnotes
The views expressed herein are those of the authors and do not necessarily reflect the official policy of the US Department of Health and Human Services, the Carter Presidential Center, the Centers for Disease Control and Prevention, or the cosponsors of the consultation held at the Carter Presidential Center.

Corresponding author: Lawrence Gostin, JD, Georgetown University Law Center, 600 New Jersey Ave NW, Washington, DC 20001 (e-mail: gostin@law.georgetown.edu).

Health Law and Ethics section editors: Lawrence O. Gostin, JD, Georgetown/ Johns Hopkins University Program on Law and Public Health, Washington, DC, and Baltimore, Md; Helene M. Cole, MD, Contributing Editor, JAMA.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Grassroots Advocacy Campaign for HIV/AIDS Prevention: Lessons From the Field
Moseley et al.
Health Promot Pract 2008;9:253-261.
ABSTRACT  

Increased Access to Unrestricted Pharmacy Sales of Syringes in Seattle-King County, Washington: Structural and Individual-Level Changes, 1996 Versus 2003
Deibert et al.
AJPH 2006;96:1347-1353.
ABSTRACT | FULL TEXT  

Temporal Trends in the Incidence of Human Immunodeficiency Virus Infection and Risk Behavior among Injection Drug Users in Baltimore, Maryland, 1988-1998
Nelson et al.
Am J Epidemiol 2002;156:641-653.
ABSTRACT | FULL TEXT  

Controlling Disease Transmission in Injection Drug Users
Kane
ANN INTERN MED 1999;130:541-544.
FULL TEXT  

Adherence and Antiretroviral Therapy in Injection Drug Users
Sherer
JAMA 1998;280:567-568.
FULL TEXT  

National HIV Case Reporting
Solomon et al.
NEJM 1998;338:626-627.
FULL TEXT  

Update: Syringe-Exchange Programs--United States, 1996
JAMA 1997;278:197-198.
ABSTRACT  

Syringe and Needle Regulation, Blood-Borne Disease Transmission, and Concern for Public Safety
Tsao and Roaf
JAMA 1997;277:1203-1203.
ABSTRACT  

Syringe and Needle Regulation, Blood-Borne Disease Transmission, and Concern for Public Safety
Friedland
JAMA 1997;277:1202-1203.
ABSTRACT